Fast Five Quiz: Pets and Human Health Risks

Richard H. Sinert, DO


May 27, 2022

Most cases of classic hookworm disease can be managed on an outpatient basis with anthelmintic and iron therapy, complemented by appropriate diet. Patients with anemia and malnutrition may require both iron supplements and nutritional support (including folate supplementation). Some patients with severe anemia and congestive heart failure may require hospitalization.

Although not approved by the US Food and Drug Administration for hookworm therapy in the United States, a 400-mg single dose of albendazole is recommended by the Centers for Disease Control and Prevention for the treatment of hookworm infection. For patients with cutaneous larva migrans who have minimal symptoms, specific anthelmintic treatment may be unnecessary.

Although benzimidazoles are an effective chemotherapeutic option, reinfection remains a notable problem because exposure to the hookworm does not confer long-term immunity.

Iron replacement and nutritional supplementation (proteins and vitamins, including folate) should be part of the management strategy and may have greater efficacy than anthelmintic therapy in reducing morbidity in selected populations (eg, pregnant women and patients who are not infected with HIV).

Learn more about the treatment of hookworm disease.

This Fast Five Quiz was excerpted and adapted from the Medscape articles Cat Scratch Disease, Fast Five Quiz: Allergy Triggers, Aeroallergens, Fast Five Quiz: Dog and Cat Bites, Salmonella Infection (Salmonellosis), and Hookworm Disease.

Follow Medscape on Facebook, Twitter, Instagram, and YouTube


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.